Tuesday, October 31, 2017

Par Pharma Suit Tests FDA's Drug Pricing Pushback

Par Pharma Suit Tests FDA's Drug Pricing Pushback

Law360-14 hours ago
It accuses the FDA of creating an "unlawful regime" that will allow compounders to churn out huge quantities of blood-pressure drug vasopressin, despite Par ...
Post a Comment